The New England journal of medicine
-
Editorial Comment
Emerging Use of CRISPR Technology - Chasing the Elusive HIV Cure.
-
Randomized Controlled Trial Multicenter Study Comparative Study
Antithrombotic Therapy for Atrial Fibrillation with Stable Coronary Disease.
There are limited data from randomized trials evaluating the use of antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease. ⋯ As antithrombotic therapy, rivaroxaban monotherapy was noninferior to combination therapy for efficacy and superior for safety in patients with atrial fibrillation and stable coronary artery disease. (Funded by the Japan Cardiovascular Research Foundation; AFIRE UMIN Clinical Trials Registry number, UMIN000016612; and ClinicalTrials.gov number, NCT02642419.).